Work

Abstract PS2-10-08: Quantitative measurement of HER2 and TROP2 predicts outcomes with trastuzumab deruxtecan in metastatic breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-10-08

Authors: C. J. Robbins, W. Wei, N. N. Chan, M. He, J. Benanto, D. B. Doroshow, I. E. Krop, D. L. Rimm

Institutions: Yale University, Icahn School of Medicine at Mount Sinai

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130720695

Cites:

Cited by:

Related to: